Is Coherent Stock Breaking Out?
Coherent (NYSE: COHR) has spent the better part of two years…
Sell
46
IH Quote, Financials, Valuation and Earnings
Last price:
$2.32
Seasonality move
:
-18.26%
Day range:
$2.31 - $2.40
52-week range:
$1.47 - $3.18
Dividend yield:
0%
P/E ratio:
9.38x
P/S ratio:
1.00x
P/B ratio:
0.93x
Volume:
5.5K
Avg. volume:
7.9K
1-year change:
31.49%
Market cap:
$122.6M
Revenue:
$128.5M
EPS (TTM):
$0.25
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, iHuman has 59.63% upside to fair value with a price target of -- per share.
IH vs. S&P 500
-
Over the past 5 trading days, iHuman has overperformed the S&P 500 by 0.93% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
iHuman does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
iHuman revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter iHuman reported revenues of $32.3M.
Earnings Growth
-
iHuman earnings have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter iHuman reported earnings per share of $0.07.
Enterprise value:
-37.5M
EV / Invested capital:
--
Price / LTM sales:
1.00x
EV / EBIT:
-3.74x
EV / Revenue:
-0.29x
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
-3.74x
Gross Profit (TTM):
$89.2M
Return On Assets:
6.99%
Net Income Margin (TTM):
10.69%
Return On Equity:
10.59%
Return On Invested Capital:
10.59%
Operating Margin:
6.41%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $146.4M | $144.1M | $128.5M | $34.8M | $32.3M | |
| Gross Profit | $102.7M | $102M | $89.2M | $24.8M | $21.7M | |
| Operating Income | $16.3M | $22.7M | $10M | $3M | $2.1M | |
| EBITDA | $16.3M | $22.7M | $10M | $3M | $2.1M | |
| Diluted EPS | $0.30 | $0.47 | $0.25 | $0.08 | $0.07 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $156.3M | $159.3M | $181.7M | $195M | $183M | |
| Total Assets | $160.2M | $172.7M | $193.3M | $204.6M | $194.5M | |
| Current Liabilities | $61.1M | $75.8M | $81.3M | $69.2M | $61.3M | |
| Total Liabilities | $61.9M | $77.3M | $81.7M | $69.5M | $62.8M | |
| Total Equity | $98.4M | $95.4M | $111.5M | $135.1M | $131.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-26 | 2024-06-26 | 2024-06-26 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
IH
Sector
Market Cap
$122.6M
$86.4M
Price % of 52-Week High
74.84%
69.66%
Dividend Yield
0%
0%
Shareholder Yield
--
3.73%
1-Year Price Total Return
31.49%
-6.79%
Beta (5-Year)
--
0.580
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.00
200-day SMA
Buy
Level
$0.00
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$0.00
Relative Strength Index (RSI14)
Buy
Level
55.24
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-10
50-day SMA
Buy
Level
$0.00
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
--
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3795)
Buy
CA Score
(Annual)
Level (0.787)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.8246)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
Stock Forecast FAQ
In the current month, IH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IH average analyst price target in the past 3 months is --.
-
Where Will iHuman Stock Be In 1 Year?
According to analysts, the consensus estimate is that iHuman share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About iHuman?
Analysts are divided on their view about iHuman share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that iHuman is a Sell and believe this share price will drop from its current level to --.
-
What Is iHuman's Price Target?
The price target for iHuman over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for iHuman is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of IH?
You can purchase shares of iHuman via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase iHuman shares.
-
What Is The iHuman Share Price Today?
iHuman was last trading at $2.32 per share. This represents the most recent stock quote for iHuman. Yesterday, iHuman closed at $2.38 per share.
-
How To Buy iHuman Stock Online?
In order to purchase iHuman stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is The Long-term Outlook for AMC Stock?
Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…
Is NuScale the Best Nuclear Stock to Buy?
NuScale Power (NYSE:SMR) is a nuclear power startup that has…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 52x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
76
AVAV alert for Jun 26
AeroVironment [AVAV] is up 14.16% over the past day.
Buy
51
SITM alert for Jun 26
SiTime [SITM] is up 2.57% over the past day.
Buy
54
NGVC alert for Jun 26
Natural Grocers by Vitamin Cottage [NGVC] is down 1.9% over the past day.
